The CXCL12/CXCR4 axis is strongly correlated with breast cancer aggressiveness and metastasis (20), whereas the CCL25/CCR9 axis provides chemotherapy resistance to breast cancer cells (21). Here, CCR9 is linked to breast carcinoma.